Cyclobenzaprine hydrochloride is a generic prescription skeletal muscle relaxant used to relieve painful muscle spasms due to musculoskeletal conditions. Cyclobenzaprine relieves muscle spasms and muscle pain by acting directly on the central nervous system (CNS), reducing muscle hyperactivity. Cyclobenzaprine is a tablet that can be taken up to three times a day for up to three weeks. It is also available as an oral extended-release capsules that only require a single daily dose.
RELATED: Learn more about cyclobenzaprine
Check our best Cyclobenzaprine prices
Detailed cyclobenzaprine dosage chart for adults |
|||
|---|---|---|---|
| Indication | Starting dose | Standard dose | Maximum dose |
| Painful muscle spasms | 5 mg tablet 3 times daily OR 15 mg capsule once daily | 5–10 mg tablet 3 times daily OR 15–30 mg capsule once daily | 30 mg/day |
| Fibromyalgia (off-label) | 5–10 mg tablet at bedtime | 5–40 mg tablets taken at bedtime or in divided doses | 20-40 mg/day |
The dosages listed are general guidelines, especially around maximum dosage; your healthcare provider may adjust your dose based on individual health factors.
For painful localized muscle spasms due to musculoskeletal conditions, cyclobenzaprine is part of a larger treatment regimen that also includes rest and physical therapy. The FDA has approved its use in adults and adolescents 15 years of age and older. It’s a short-term therapy, meant only to be used for short periods of two to three weeks.
Although cyclobenzaprine is only approved to provide relief of muscle spasms, healthcare providers sometimes prescribe it off-label to relieve sleep disturbances due to fibromyalgia. Dosing is typically done at bedtime to assist with sleep, but very large daily doses can be divided throughout the day. Because cyclobenzaprine is prescribed off-label for fibromyalgia, dosing and treatment duration have not been standardized. The maximum daily dosage for fibromyalgia is 40 mg per day according to some studies, but lower doses like 20 mg/day are preferable.
Because cyclobenzaprine is broken down by the liver, people with impaired liver function may become more sedated when taking cyclobenzaprine than other patients. As a result, healthcare providers always start with the lowest dose of short-acting cyclobenzaprine, 5 mg daily in those with mild liver disease, and the medication is best avoided in patients with moderate to severe liver disease. The dose can be slowly increased if necessary while monitoring carefully. Extended-release cyclobenzaprine is avoided in elderly patients and in those with liver impairment.
No dose adjustment is indicated in those with altered kidney function, but caution is recommended due to lack of safety and efficacy data.
The most common side effects are drowsiness, dizziness, confusion, and dry mouth. Because of the risk for serious side effects, the FDA has approved cyclobenzaprine only for short-term use.
The use of cyclobenzaprine is contraindicated in people with:
Known allergies to the drug
Heart rhythm problems
Heart block
Overactive thyroid
Recently had a heart attack
Immediately stop using cyclobenzaprine and contact the prescriber or get medical attention if you experience symptoms of an allergic reaction or irregular heartbeat.
The most important safety concern is that cyclobenzaprine, as a CNS depressant, causes sedation, somnolence, dizziness, and confusion. Do not drive or engage in any other risky activities until you know how doses affect you. Do not drink alcohol on the days you take cyclobenzaprine.
Precautions are needed when cyclobenzaprine is used in people with:
A history of urinary retention
High eye pressure
Cyclobenzaprine is not considered absolutely contraindicated in pregnancy, but its safety is not fully established. Use should be reserved for situations where benefits clearly outweigh risks, with preference for short-term, low-dose therapy, and close monitoring for adverse effects is recommended.
Cyclobenzaprine is excreted into human milk in low concentrations, with a calculated relative infant dose (RID) of approximately 0.5% of the maternal weight-adjusted dose—well below the commonly accepted threshold of concern (10%) for most medications during lactation. However, cyclobenzaprine possesses sedative properties, and the medical literature recommends regular clinical assessment of the infant for signs of sedation, poor feeding, or other adverse effects if maternal use is necessary.
Cyclobenzaprine has several drug interactions that can cause serious complications. Make sure the prescriber knows about all medications being used before starting this drug. Here are the most important:
Monoamine oxidase inhibitors (MAOIs)
MAO inhibitors are contraindicated for use with cyclobenzaprine. They cannot be used within 14 days before or after a cyclobenzaprine dose.
Drugs that also cause sedation
Narcotic pain relievers, sedatives (benzodiazepines), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, sleeping pills, barbiturates, and alcohol. Concomitant use of these drugs can worsen the sedative effects of cyclobenzaprine.
Drugs that work like cyclobenzaprine, called serotonergic drugs
Taking more than one drug that raises serotonin levels can cause serotonin syndrome, a potentially severe condition caused by too much serotonin in the brain. These include antidepressants, other drugs that treat mental health issues, opioids, migraine medications, and others.
The health care provider is not required to gradually reduce the dose when it’s time to stop, but some people may experience adverse effects, including nausea, vomiting, sweating, and insomnia. To forestall these problems, some clinicians may choose to taper the dose at discontinuation, but there is no set tapering schedule.
Cyclobenzaprine is taken by mouth as either a tablet or a capsule. Follow all the prescriber’s directions, and do not take more than the recommended dosage.
This medicine is not for long-term use.
Take this medicine at the same time each day.
Doses can be taken with or without food.
If tablets or capsules cause stomach problems, try taking the dose with food.
Tablets can be taken three times a day.
Swallow the cyclobenzaprine oral tablet whole with a glass of water.
Cyclobenzaprine extended-release capsules are taken once per day at the same time each day.
Swallow the oral extended-release capsule whole. Do not crush, break, or chew the capsules or granules inside the capsule.
If you cannot swallow the capsule whole:
Open the capsule and sprinkle the contents over one tablespoon of applesauce. Do not use any food other than applesauce.
Swallow the mixture immediately without chewing.
Rinse your mouth to ensure all of the medicine has been swallowed.
Do not save any of the mixture to use later.
Cyclobenzaprine tablets or capsules should be stored at room temperature in a tightly closed container away from light and out of the reach of children.
15 mg/day, either 5 mg cyclobenzaprine immediate release (IR) taken three times daily or 15 mg cyclobenzaprine extended release (ER) taken once daily.
Take only three doses of immediate-release cyclobenzaprine or one dose of extended-release cyclobenzaprine in a 24-hour period.
Elderly patients are typically started on a lower dose because of the greater risk of side effects, but the maximum dosage can be the same as it is for younger adults. Although caution is recommended, clinicians should look at other medications to avoid drug interactions. Clinicians avoid prescribing extended-release cyclobenzaprine to older adults.
The doctor may change the initial cyclobenzaprine dose if the lower dose is inadequate for controlling pain. There are only two dosages for both immediate-release and extended-release cyclobenzaprine: 15 mg/day or 30 mg/day. Treatment only lasts two or three weeks.
Take a dose as soon as you remember. If it is almost time for the next dose, wait until then and take that dose. Do not take extra medicine to make up for a missed dose.
Cyclobenzaprine, StatPearls
Cyclobenzaprine capsule prescribing information, DailyMed (NIH National Library of Medicine)
Cyclobenzaprine hydrochloride tablet prescribing information, DailyMed (NIH National Library of Medicine)
Flexeril drug summary, Prescriber’s Digital Reference (PDR)
Muscle relaxants (toxicity), Merck Veterinary Manual
Symptoms of withdrawal from tricyclic antidepressants, Canadian Medical Association Journal
Chad Shaffer, MD, earned his medical doctorate from Penn State University and completed a combined Internal Medicine and Pediatrics residency at the University of Pittsburgh Medical Center and Children’s Hospital of Pittsburgh. He is board certified by the American Board of Internal Medicine and the American Board of Pediatrics. He has provided full-service primary care to all ages for over 15 years, building a practice from start up to over 3,000 patients. His passion is educating patients on their health and treatment, so they can make well-informed decisions.
...Health education, drug info, wellness & more
Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price. This is a medical discount plan. This is NOT insurance. This program offers you the opportunity to locate providers of various types of medical services who will offer their services to you at discounted rates. The range of discounts for medical or ancillary services provided under the plan will vary depending on the type of provider and service received. You are fully responsible for paying for all health care services but will be entitled to receive a discount from those health care providers in accordance with the specific pre-negotiated discounted fee schedule. This program does not guarantee the quality of the services or procedures offered by the providers. Except for prescription drugs which you will pay directly to the pharmacy at the time of purchase, all other services received through a program provider will be charged to the credit card on file in your member account. The charge will include an administrative fee for use of the program. Towers Administrators LLC is the licensed discount medical plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services, LLC is the marketer of the discount medical plan organization including its website, singlecare.com, with its corporate office located at 99 High Street, Suite 2800, Boston, MA 02110. For additional information, including an up-to-date list of providers, or assistance with any issue related to program membership, please contact member support any time at www.singlecare.com, or by calling toll-free 844-234-3057, 24 hours, 7 days a week (except major holidays). Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Blog articles are not medical advice. They are intended for general informational purposes and are not meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, immediately call your physician or dial 911.
© 2025 SingleCare Administrators. All rights reserved
© 2025 SingleCare Administrators. All rights reserved